RECENT FUNDING ROUNDS


Country Profile Funding round Value Date
ValenzaBio Inc antibody for inflammatory eye disease Series A USD 70,000,000
Blossomhill Therapeutics Inc Biotechnology company focused on oncology and autoimmune disorders. Series A USD 71,000,000
Maridose LLC Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs. Pre Seed USD 150,000
Perfect Day Inc Series C USD 140,000,000
Quell Therapeutics Ltd Developer of engineered T regulatory cell therapies. Series A GBP 35,000,000
Aquaro Histology Inc Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory. Series A USD 9,810,879
3SBio Inc IPO HKD 5,510,000,000
Wyeth Pharmaceuticals Acquisition USD 68,000,000,000

MOST ACTIVE ACQUIRERS

Pfizer Inc US 1

BEST FUNDED


Biotechnology company focused on oncology and autoimmune disorders.

Provider of solutions that improve workflow efficiency, section quality, and consistency in the histology laboratory.

Biotech - Cannabis R&D. We are a US DEA licensed manufacturer of Schedule 1 drugs.

Elevate Ventures nurtures and develops emerging and existing high-potential businesses into high-performing, Indiana-based companies.

Developer of engineered T regulatory cell therapies.

Biotechnology company developing a new class of therapies for metabolic diseases and disorders.

antibody for inflammatory eye disease